Global Healthcare Investment Banking Market By Services (Advisory Services – Mergers & Acquisition Advisory Services, Capital Raising, Strategic Restructurings, Others, Capital Markets – Acquisition Financing, Project Financing, Equity Private Placement, Venture Capital, Liability Management, Second Lien Loans, Debt and Equity Recapitalizalizations, Others, Others); By Organization Size (Small and Medium Organizations, Large Organizations); By Sector (Pharmaceuticals – Generics and Specialty Pharmaceuticals, Biopharma, Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.), Others, Healthcare Delivery – Hospitals, Managed Care Facilities, Private Practices, Diagnostics, Home Health, Hospice, and Other Post-Acute, Behavioral Health, Pre-Acute and Acute Care, and Others, Medical Technology – Life Sciences & Diagnostic Tools, Medical Devices & Equipment, Biotechnology, Medical Supplies & Consumables, Others, Healthcare Information Technology (HCIT), Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030

Table of Contents

1.     Market Scope

1.1.   Market Segmentation

1.2.   Years Considered

1.2.1.   Historic Years: 2015 - 2020

1.2.2.   Base Year: 2021

1.2.3.   Forecast Years: 2022 – 2030

2.     Key Target Audiences

3.     Research Methodology

3.1.   Primary Research

3.1.1.   Research Questionnaire

3.1.2.   Global Percentage Breakdown

3.1.3.   Primary Interviews: Key Opinion Leaders (KOLs)

3.2.   Secondary Research

3.2.1.   Paid Databases

3.2.2.   Secondary Sources

3.3.   Market Size Estimates

3.3.1.   Top-Down Approach

3.3.2.   Bottom-Up Approach

3.4.   Data Triangulation Methodology

3.5.   Research Assumptions

4.     Recommendations and Insights from AMI’s Perspective**

5.     Holistic Overview of Healthcare Investment Banking Market

6.     Market Synopsis: Healthcare Investment Banking Market

7.     Healthcare Investment Banking Market Analysis: Qualitative Perspective

7.1.   Introduction

7.1.1.   Product Definition

7.1.2.   Industry Development

7.2.   Market Dynamics

7.2.1.   Drivers

7.2.2.   Restraints

7.2.3.   Opportunities

7.2.4.   Challenges

7.3.   Trends in Healthcare Investment Banking Market

7.4.   Market Determinants Radar Chart

7.5.   Macro-Economic and Micro-Economic Indicators: Healthcare Investment Banking Market

7.6.   Porter’s Five Force Analysis

7.7.   Impact of Covid-19 on Healthcare Investment Banking Market

8.     Global Healthcare Investment Banking Market Analysis and Forecasts, 2022 – 2030

8.1.   Overview

8.1.1.   Global Healthcare Investment Banking Market Revenue (US$ Mn)

8.2.   Global Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

8.2.1.   Advisory Services (Definition, Market Estimation and Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Mergers and Acquisition Advisory Services, Capital Raising, Strategic Restructurings, Others)

8.2.1.1.      Mergers and Acquisition Advisory Services

8.2.1.2.      Capital Raising

8.2.1.3.      Strategic Restructurings

8.2.1.4.      Others

8.2.2.   Capital Markets (Definition, Market Estimation and Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Acquisition Financing, Project Financing, Equity Private Placement, Venture Capital, Liability Management, Second Lien loans, Debt and Equity Recapitalizations, Others)

8.2.2.1.      Acquisition Financing

8.2.2.2.      Project Financing

8.2.2.3.      Equity Private Placement

8.2.2.4.      Venture Capital

8.2.2.5.      Liability Management

8.2.2.6.      Second Lien loans

8.2.2.7.      Debt and Equity Recapitalizations

8.2.2.8.      Others

8.2.3.   Others

8.2.3.1.      Definition

8.2.3.2.      Market Estimation and Penetration, 2015 – 2021

8.2.3.3.      Market Forecast, 2022 – 2030

8.2.3.4.      Compound Annual Growth Rate (CAGR)

8.2.3.5.      Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1.    Market Estimation, 2015 – 2021

8.2.3.5.1.2.    Market Forecast, 2022 – 2030

8.2.3.5.2. Europe

8.2.3.5.2.1.    Market Estimation, 2015 – 2021

8.2.3.5.2.2.    Market Forecast, 2022 – 2030

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1.    Market Estimation, 2015 – 2021

8.2.3.5.3.2.    Market Forecast, 2022 – 2030

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1.    Market Estimation, 2015 – 2021

8.2.3.5.4.2.    Market Forecast, 2022 – 2030

8.2.3.5.5. Latin America

8.2.3.5.5.1.    Market Estimation, 2015 – 2021

8.2.3.5.5.2.    Market Forecast, 2022 – 2030

8.3.   Key Segment for Channeling Investments

8.3.1.   By Services

9.     Global Healthcare Investment Banking Market Analysis and Forecasts, 2022 – 2030

9.1.   Overview

9.2.   Global Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

9.2.1.   Small and Medium Organizations

9.2.1.1.      Definition

9.2.1.2.      Market Estimation and Penetration, 2015 – 2021

9.2.1.3.      Market Forecast, 2022 – 2030

9.2.1.4.      Compound Annual Growth Rate (CAGR)

9.2.1.5.      Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1.    Market Estimation, 2015 – 2021

9.2.1.5.1.2.    Market Forecast, 2022 – 2030

9.2.1.5.2. Europe

9.2.1.5.2.1.    Market Estimation, 2015 – 2021

9.2.1.5.2.2.    Market Forecast, 2022 – 2030

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1.    Market Estimation, 2015 – 2021

9.2.1.5.3.2.    Market Forecast, 2022 – 2030

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1.    Market Estimation, 2015 – 2021

9.2.1.5.4.2.    Market Forecast, 2022 – 2030

9.2.1.5.5. Latin America

9.2.1.5.5.1.    Market Estimation, 2015 – 2021

9.2.1.5.5.2.    Market Forecast, 2022 – 2030

9.2.2.                             Large Organizations

9.2.2.1.      Definition

9.2.2.2.      Market Estimation and Penetration, 2015 – 2021

9.2.2.3.      Market Forecast, 2022 – 2030

9.2.2.4.      Compound Annual Growth Rate (CAGR)

9.2.2.5.      Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1.    Market Estimation, 2015 – 2021

9.2.2.5.1.2.    Market Forecast, 2022 – 2030

9.2.2.5.2. Europe

9.2.2.5.2.1.    Market Estimation, 2015 – 2021

9.2.2.5.2.2.    Market Forecast, 2022 – 2030

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1.    Market Estimation, 2015 – 2021

9.2.2.5.3.2.    Market Forecast, 2022 – 2030

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1.    Market Estimation, 2015 – 2021

9.2.2.5.4.2.    Market Forecast, 2022 – 2030

9.2.2.5.5. Latin America

9.2.2.5.5.1.    Market Estimation, 2015 – 2021

9.2.2.5.5.2.    Market Forecast, 2022 – 2030

9.3.   Key Segment for Channeling Investments

9.3.1.   By Organization Size

10.   Global Healthcare Investment Banking Market Analysis and Forecasts, 2022 – 2030

10.1.   Overview

10.2.   Global Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

10.2.1.  Pharmaceuticals (Definition, Market Estimation and Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Generics and Specialty Pharmaceuticals, Biopharma, Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.), Others)

10.2.1.1.   Generics and Specialty Pharmaceuticals

10.2.1.2.   Biopharma

10.2.1.3.   Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

10.2.1.4.   Others

10.2.2.  Healthcare Delivery (Definition, Market Estimation and Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Hospitals, Managed Care Facilities, Private Practices, Diagnostics, Home Health, Hospice and Other Post- Acute, Behavioral Health, Pre-Acute and Acute Care, Others)

10.2.2.1.   Hospitals

10.2.2.2.   Managed Care Facilities

10.2.2.3.   Private Practices

10.2.2.4.   Diagnostics

10.2.2.5.   Home Health, Hospice and Other Post-Acute

10.2.2.6.   Behavioral Health

10.2.2.7.   Pre-Acute and Acute Care

10.2.2.8.   Others

10.2.3.  Medical Technology (Definition, Market Estimation and Penetration, 2015 – 2021, Market Estimation (2015 – 2021), Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Life Sciences and Diagnostic Tools, Medical Devices and Equipment, Biotechnology, Medical Supplies and Consumables, Others)

10.2.3.1.   Life Sciences and Diagnostic Tools

10.2.3.2.   Medical Devices and Equipment

10.2.3.3.   Biotechnology

10.2.3.4.   Medical Supplies and Consumables

10.2.3.5.   Others

10.2.4.   Healthcare Information Technology (HCIT)

10.2.4.1.   Definition

10.2.4.2.   Market Estimation and Penetration, 2015 – 2021

10.2.4.3.   Market Forecast, 2022 – 2030

10.2.4.4.   Compound Annual Growth Rate (CAGR)

10.2.4.5.   Regional Bifurcation

10.2.4.5.1. North America

10.2.4.5.1.1.    Market Estimation, 2015 – 2021

10.2.4.5.1.2.    Market Forecast, 2022 – 2030

10.2.4.5.2. Europe

10.2.4.5.2.1.    Market Estimation, 2015 – 2021

10.2.4.5.2.2.    Market Forecast, 2022 – 2030

10.2.4.5.3. Asia Pacific

10.2.4.5.3.1.    Market Estimation, 2015 – 2021

10.2.4.5.3.2.    Market Forecast, 2022 – 2030 10.2.4.5.4. Middle East and Africa

10.2.4.5.4.1.    Market Estimation, 2015 – 2021

10.2.4.5.4.2.    Market Forecast, 2022 – 2030

10.2.4.5.5.   Latin America

10.2.4.5.5.1.    Market Estimation, 2015 – 2021

10.2.4.5.5.2.    Market Forecast, 2022 – 2030

10.2.5.   Others

10.2.5.1.   Definition

10.2.5.2.   Market Estimation and Penetration, 2015 – 2021

10.2.5.3.   Market Forecast, 2022 – 2030

10.2.5.4.   Compound Annual Growth Rate (CAGR)

10.2.5.5.   Regional Bifurcation

10.2.5.5.1. North America

10.2.5.5.1.1.    Market Estimation, 2015 – 2021

10.2.5.5.1.2.    Market Forecast, 2022 – 2030

10.2.5.5.2. Europe

10.2.5.5.2.1.    Market Estimation, 2015 – 2021

10.2.5.5.2.2.    Market Forecast, 2022 – 2030

10.2.5.5.3. Asia Pacific

10.2.5.5.3.1.    Market Estimation, 2015 – 2021

10.2.5.5.3.2.    Market Forecast, 2022 – 2030 10.2.5.5.4. Middle East and Africa

10.2.5.5.4.1.    Market Estimation, 2015 – 2021

10.2.5.5.4.2.    Market Forecast, 2022 – 2030

10.2.5.5.5.   Latin America

10.2.5.5.5.1.    Market Estimation, 2015 – 2021

10.2.5.5.5.2.    Market Forecast, 2022 – 2030

10.3.    Key Segment for Channeling Investments

10.3.1.   By Sector

11.   North America Healthcare Investment Banking Market Analysis and Forecasts, 2022 - 2030

11.1.   Overview

11.1.1.   North America Healthcare Investment Banking Market Revenue (US$ Mn)

11.2.  North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

11.2.1.   Advisory Services

11.2.1.1.   Mergers and Acquisition Advisory Services

11.2.1.2.   Capital Raising

11.2.1.3.   Strategic Restructurings

11.2.1.4.   Others

11.2.2.   Capital Markets

11.2.2.1.   Acquisition Financing

11.2.2.2.   Project Financing

11.2.2.3.   Equity Private Placement

11.2.2.4.   Venture Capital

11.2.2.5.   Liability Management

11.2.2.6.   Second Lien loans

11.2.2.7.   Debt and Equity Recapitalizations

11.2.2.8.   Others

11.2.3.   Others

11.3.  North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.3.1.   Small and Medium Organizations

11.3.2.   Large Organizations

11.4.  North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

11.4.1.   Pharmaceuticals

11.4.1.1.   Generics and Specialty Pharmaceuticals

11.4.1.2.   Biopharma

11.4.1.3.   Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

11.4.1.4.   Others

11.4.2.   Healthcare Delivery

11.4.2.1.   Hospitals

11.4.2.2.   Managed Care Facilities

11.4.2.3.   Private Practices

11.4.2.4.   Diagnostics

11.4.2.5.   Home Health, Hospice and Other Post-Acute

11.4.2.6.   Behavioral Health

11.4.2.7.   Pre-Acute and Acute Care

11.4.2.8.   Others

11.4.3.   Medical Technology

11.4.3.1.   Life Sciences and Diagnostic Tools

11.4.3.2.   Medical Devices and Equipment

11.4.3.3.   Biotechnology

11.4.3.4.   Medical Supplies and Consumables

11.4.3.5.   Others

11.4.4.   Healthcare Information Technology (HCIT)

11.4.5.   Others

11.5.  North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

11.5.1.   U.S

11.5.1.1.   U.S Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

11.5.1.1.1. Advisory Services

11.5.1.1.1.1.    Mergers and Acquisition Advisory Services 11.5.1.1.1.2. Capital Raising

11.5.1.1.1.3.    Strategic Restructurings

11.5.1.1.1.4.    Others

11.5.1.1.2. Capital Markets

11.5.1.1.2.1.    Acquisition Financing

11.5.1.1.2.2.    Project Financing 11.5.1.1.2.3. Equity Private Placement 11.5.1.1.2.4. Venture Capital

11.5.1.1.2.5. Liability Management 11.5.1.1.2.6. Second Lien loans

11.5.1.1.2.7. Debt and Equity Recapitalizations 11.5.1.1.2.8. Others

11.5.1.1.3. Others

11.5.1.2.   U.S Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.5.1.2.1. Small and Medium Organizations 11.5.1.2.2. Large Organizations

11.5.1.3.   U.S Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

11.5.1.3.1. Pharmaceuticals

11.5.1.3.1.1.    Generics and Specialty Pharmaceuticals 11.5.1.3.1.2. Biopharma

11.5.1.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

11.5.1.3.1.4.                                                                                                 Others

11.5.1.3.2. Healthcare Delivery

11.5.1.3.2.1.    Hospitals

11.5.1.3.2.2.    Managed Care Facilities 11.5.1.3.2.3. Private Practices

11.5.1.3.2.4.    Diagnostics

11.5.1.3.2.5.    Home Health, Hospice and Other Post-Acute 11.5.1.3.2.6. Behavioral Health

11.5.1.3.2.7. Pre-Acute and Acute Care 11.5.1.3.2.8. Others

11.5.1.3.3. Medical Technology

11.5.1.3.3.1.    Life Sciences and Diagnostic Tools 11.5.1.3.3.2. Medical Devices and Equipment 11.5.1.3.3.3. Biotechnology

11.5.1.3.3.4. Medical Supplies and Consumables 11.5.1.3.3.5. Others

11.5.2.   Canada

11.5.2.1.1. Healthcare Information Technology (HCIT) 11.5.1.3.5. Others

11.5.2.2.   Canada Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

11.5.2.2.1. Advisory Services

11.5.2.2.1.1.    Mergers and Acquisition Advisory Services 11.5.2.1.1.2. Capital Raising

11.5.2.1.1.3.    Strategic Restructurings

11.5.2.1.1.4.    Others

11.5.2.2.2. Capital Markets

11.5.2.2.2.1.    Acquisition Financing

11.5.2.2.2.2.    Project Financing 11.5.2.1.2.3. Equity Private Placement 11.5.2.1.2.4. Venture Capital

11.5.2.1.2.5. Liability Management 11.5.2.1.2.6. Second Lien loans

11.5.2.1.2.7. Debt and Equity Recapitalizations 11.5.2.1.2.8. Others

11.5.2.2.3. Others

11.5.2.3.   Canada Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.5.2.3.1. Small and Medium Organizations 11.5.2.2.2. Large Organizations

11.5.2.4.   Canada Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

11.5.2.4.1. Pharmaceuticals

11.5.2.4.1.1.    Generics and Specialty Pharmaceuticals 11.5.2.3.1.2. Biopharma

11.5.2.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

11.5.2.3.1.4. Others

11.5.2.4.2. Healthcare Delivery

11.5.2.4.2.1.    Hospitals

11.5.2.4.2.2.    Managed Care Facilities 11.5.2.3.2.3. Private Practices

11.5.2.3.2.4.    Diagnostics

11.5.2.3.2.5.    Home Health, Hospice and Other Post-Acute 11.5.2.3.2.6. Behavioral Health

11.5.3.   Mexico

11.5.2.3.2.7. Pre-Acute and Acute Care 11.5.2.3.2.8. Others

11.5.3.1.1. Medical Technology

11.5.3.1.1.1.    Life Sciences and Diagnostic Tools 11.5.2.3.3.2. Medical Devices and Equipment 11.5.2.3.3.3. Biotechnology

11.5.2.3.3.4. Medical Supplies and Consumables 11.5.2.3.3.5. Others

11.5.3.1.2. Healthcare Information Technology (HCIT) 11.5.2.3.5. Others

11.5.3.2.   Mexico Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

11.5.3.2.1. Advisory Services

11.5.3.2.1.1.    Mergers and Acquisition Advisory Services 11.5.3.1.1.2. Capital Raising

11.5.3.1.1.3.    Strategic Restructurings

11.5.3.1.1.4.    Others

11.5.3.2.2. Capital Markets

11.5.3.2.2.1.    Acquisition Financing

11.5.3.2.2.2.    Project Financing 11.5.3.1.2.3. Equity Private Placement 11.5.3.1.2.4. Venture Capital

11.5.3.1.2.5. Liability Management 11.5.3.1.2.6. Second Lien loans

11.5.3.1.2.7. Debt and Equity Recapitalizations 11.5.3.1.2.8. Others

11.5.3.2.3. Others

11.5.3.3.   Mexico Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.5.3.3.1. Small and Medium Organizations 11.5.3.2.2. Large Organizations

11.5.3.4.   Mexico Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

11.5.3.4.1. Pharmaceuticals

11.5.3.4.1.1.    Generics and Specialty Pharmaceuticals 11.5.3.3.1.2. Biopharma

11.5.3.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

11.5.3.3.1.4.                                                                                                 Others

11.5.3.4.2. Healthcare Delivery

11.5.3.4.2.1.    Hospitals

11.5.3.4.2.2.    Managed Care Facilities 11.5.3.3.2.3. Private Practices

11.5.3.3.2.4.    Diagnostics

11.5.3.3.2.5.    Home Health, Hospice and Other Post-Acute 11.5.3.3.2.6. Behavioral Health

11.5.3.3.2.7. Pre-Acute and Acute Care 11.5.3.3.2.8. Others

11.5.3.4.3. Medical Technology

11.5.3.4.3.1.    Life Sciences and Diagnostic Tools 11.5.3.3.3.2. Medical Devices and Equipment 11.5.3.3.3.3. Biotechnology

11.5.3.3.3.4. Medical Supplies and Consumables 11.5.3.3.3.5. Others

11.5.3.4.4. Healthcare Information Technology (HCIT) 11.5.3.3.5. Others

11.5.4.   Rest of North America

11.5.4.1.   Rest of North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

11.5.4.1.1. Advisory Services

11.5.4.1.1.1.    Mergers and Acquisition Advisory Services 11.5.4.1.1.2. Capital Raising

11.5.4.1.1.3.    Strategic Restructurings

11.5.4.1.1.4.    Others

11.5.4.1.2. Capital Markets

11.5.4.1.2.1.    Acquisition Financing

11.5.4.1.2.2.    Project Financing 11.5.4.1.2.3. Equity Private Placement 11.5.4.1.2.4. Venture Capital

11.5.4.1.2.5. Liability Management 11.5.4.1.2.6. Second Lien loans

11.5.4.1.2.7. Debt and Equity Recapitalizations 11.5.4.1.2.8. Others

11.5.4.1.3. Others

11.5.4.2.   Rest of North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

11.5.4.2.1. Small and Medium Organizations

11.5.4.2.2. Large Organizations

11.5.4.3.   Rest of North America Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

11.5.4.3.1. Pharmaceuticals

11.5.4.3.1.1.    Generics and Specialty Pharmaceuticals 11.5.4.3.1.2. Biopharma

11.5.4.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

11.5.4.3.1.4.                                                                                                 Others

11.5.4.3.2. Healthcare Delivery

11.5.4.3.2.1.    Hospitals

11.5.4.3.2.2.    Managed Care Facilities 11.5.4.3.2.3. Private Practices

11.5.4.3.2.4.    Diagnostics

11.5.4.3.2.5.    Home Health, Hospice and Other Post-Acute 11.5.4.3.2.6. Behavioral Health

11.5.4.3.2.7. Pre-Acute and Acute Care 11.5.4.3.2.8. Others

11.5.4.3.3. Medical Technology

11.5.4.3.3.1.    Life Sciences and Diagnostic Tools 11.5.4.3.3.2. Medical Devices and Equipment 11.5.4.3.3.3. Biotechnology

11.5.4.3.3.4. Medical Supplies and Consumables 11.5.4.3.3.5. Others

11.5.4.3.4. Healthcare Information Technology (HCIT) 11.5.4.3.5. Others

11.6.   Key Segment for Channeling Investments

11.6.1.   By Country

11.6.2.   By Services

11.6.3.   By Organization Size

11.6.4.   By Sector

12.   Europe Healthcare Investment Banking Market Analysis and Forecasts, 2022 - 2030

12.1.   Overview

12.1.1.   Europe Healthcare Investment Banking Market Revenue (US$ Mn)

12.2.  Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.2.1.   Advisory Services

12.2.1.1.   Mergers and Acquisition Advisory Services

12.2.1.2.   Capital Raising

12.2.1.3.   Strategic Restructurings

12.2.1.4.   Others

12.2.2.   Capital Markets

12.2.2.1.   Acquisition Financing

12.2.2.2.   Project Financing

12.2.2.3.   Equity Private Placement

12.2.2.4.   Venture Capital

12.2.2.5.   Liability Management

12.2.2.6.   Second Lien loans

12.2.2.7.   Debt and Equity Recapitalizations

12.2.2.8.   Others

12.2.3.   Others

12.3.  Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.3.1.   Small and Medium Organizations

12.3.2.   Large Organizations

12.4.  Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.4.1.   Pharmaceuticals

12.4.1.1.   Generics and Specialty Pharmaceuticals

12.4.1.2.   Biopharma

12.4.1.3.   Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.4.1.4.   Others

12.4.2.   Healthcare Delivery

12.4.2.1.   Hospitals

12.4.2.2.   Managed Care Facilities

12.4.2.3.   Private Practices

12.4.2.4.   Diagnostics

12.4.2.5.   Home Health, Hospice and Other Post-Acute

12.4.2.6.   Behavioral Health

12.4.2.7.   Pre-Acute and Acute Care

12.4.2.8.   Others

12.4.3.   Medical Technology

12.4.3.1.   Life Sciences and Diagnostic Tools

12.4.3.2.   Medical Devices and Equipment

12.4.3.3.   Biotechnology

12.4.3.4.   Medical Supplies and Consumables

12.4.3.5.   Others

12.4.4.   Healthcare Information Technology (HCIT)

12.4.5.   Others

12.5.  Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

12.5.1.   France

12.5.1.1.   France Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.1.1.1. Advisory Services

12.5.1.1.1.1.    Mergers and Acquisition Advisory Services 12.5.1.1.1.2. Capital Raising

12.5.1.1.1.3.    Strategic Restructurings

12.5.1.1.1.4.    Others

12.5.1.1.2. Capital Markets

12.5.1.1.2.1.    Acquisition Financing

12.5.1.1.2.2.    Project Financing 12.5.1.1.2.3. Equity Private Placement 12.5.1.1.2.4. Venture Capital

12.5.1.1.2.5. Liability Management 12.5.1.1.2.6. Second Lien loans

12.5.1.1.2.7. Debt and Equity Recapitalizations 12.5.1.1.2.8. Others

12.5.1.1.3. Others

12.5.1.2.   France Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.1.2.1. Small and Medium Organizations 12.5.1.2.2. Large Organizations

12.5.1.3.   France Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.1.3.1. Pharmaceuticals

12.5.1.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.1.3.1.2. Biopharma

12.5.1.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.1.3.1.4.                                                                                                 Others

12.5.1.3.2. Healthcare Delivery

12.5.1.3.2.1.    Hospitals

12.5.1.3.2.2.    Managed Care Facilities 12.5.1.3.2.3. Private Practices

12.5.1.3.2.4.    Diagnostics

12.5.2.   The UK

12.5.1.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.1.3.2.6. Behavioral Health

12.5.1.3.2.7. Pre-Acute and Acute Care 12.5.1.3.2.8. Others

12.5.2.1.1. Medical Technology

12.5.2.1.1.1.    Life Sciences and Diagnostic Tools 12.5.1.3.3.2. Medical Devices and Equipment 12.5.1.3.3.3. Biotechnology

12.5.1.3.3.4. Medical Supplies and Consumables 12.5.1.3.3.5. Others

12.5.2.1.2. Healthcare Information Technology (HCIT) 12.5.1.3.5. Others

12.5.2.2.   The UK Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.2.2.1. Advisory Services

12.5.2.2.1.1.    Mergers and Acquisition Advisory Services 12.5.2.1.1.2. Capital Raising

12.5.2.1.1.3.    Strategic Restructurings

12.5.2.1.1.4.    Others

12.5.2.2.2. Capital Markets

12.5.2.2.2.1.    Acquisition Financing

12.5.2.2.2.2.    Project Financing 12.5.2.1.2.3. Equity Private Placement 12.5.2.1.2.4. Venture Capital

12.5.2.1.2.5. Liability Management 12.5.2.1.2.6. Second Lien loans

12.5.2.1.2.7. Debt and Equity Recapitalizations 12.5.2.1.2.8. Others

12.5.2.2.3. Others

12.5.2.3.   The UK Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.2.3.1. Small and Medium Organizations 12.5.2.2.2. Large Organizations

12.5.2.4.   The UK Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.2.4.1. Pharmaceuticals

12.5.2.4.1.1.    Generics and Specialty Pharmaceuticals 12.5.2.3.1.2. Biopharma

12.5.3.   Spain

12.5.2.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.2.3.1.4.                                     Others

12.5.3.1.1. Healthcare Delivery

12.5.3.1.1.1.    Hospitals

12.5.3.1.1.2.    Managed Care Facilities 12.5.2.3.2.3. Private Practices

12.5.2.3.2.4.    Diagnostics

12.5.2.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.2.3.2.6. Behavioral Health

12.5.2.3.2.7. Pre-Acute and Acute Care 12.5.2.3.2.8. Others

12.5.3.1.2. Medical Technology

12.5.3.1.2.1.    Life Sciences and Diagnostic Tools 12.5.2.3.3.2. Medical Devices and Equipment 12.5.2.3.3.3. Biotechnology

12.5.2.3.3.4. Medical Supplies and Consumables 12.5.2.3.3.5. Others

12.5.3.1.3. Healthcare Information Technology (HCIT) 12.5.2.3.5. Others

12.5.3.2.   Spain Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.3.2.1. Advisory Services

12.5.3.2.1.1.    Mergers and Acquisition Advisory Services 12.5.3.1.1.2. Capital Raising

12.5.3.1.1.3.    Strategic Restructurings

12.5.3.1.1.4.    Others

12.5.3.2.2. Capital Markets

12.5.3.2.2.1.    Acquisition Financing

12.5.3.2.2.2.    Project Financing 12.5.3.1.2.3. Equity Private Placement 12.5.3.1.2.4. Venture Capital

12.5.3.1.2.5. Liability Management 12.5.3.1.2.6. Second Lien loans

12.5.3.1.2.7. Debt and Equity Recapitalizations 12.5.3.1.2.8. Others

12.5.3.2.3. Others

12.5.3.3.   Spain Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.3.3.1. Small and Medium Organizations 12.5.3.2.2. Large Organizations

12.5.3.4.   Spain Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.3.4.1. Pharmaceuticals

12.5.3.4.1.1.    Generics and Specialty Pharmaceuticals 12.5.3.3.1.2. Biopharma

12.5.3.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.3.3.1.4.                                                                                                 Others

12.5.3.4.2. Healthcare Delivery

12.5.3.4.2.1.    Hospitals

12.5.3.4.2.2.    Managed Care Facilities 12.5.3.3.2.3. Private Practices

12.5.3.3.2.4.    Diagnostics

12.5.3.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.3.3.2.6. Behavioral Health

12.5.3.3.2.7. Pre-Acute and Acute Care 12.5.3.3.2.8. Others

12.5.3.4.3. Medical Technology

12.5.3.4.3.1.    Life Sciences and Diagnostic Tools 12.5.3.3.3.2. Medical Devices and Equipment 12.5.3.3.3.3. Biotechnology

12.5.3.3.3.4. Medical Supplies and Consumables 12.5.3.3.3.5. Others

12.5.3.4.4. Healthcare Information Technology (HCIT) 12.5.3.3.5. Others

12.5.4.   Germany

12.5.4.1.   Germany Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.4.1.1. Advisory Services

12.5.4.1.1.1.    Mergers and Acquisition Advisory Services 12.5.4.1.1.2. Capital Raising

12.5.4.1.1.3.    Strategic Restructurings

12.5.4.1.1.4.    Others

12.5.4.1.2. Capital Markets

12.5.4.1.2.1.    Acquisition Financing

12.5.4.1.2.2.    Project Financing 12.5.4.1.2.3. Equity Private Placement 12.5.4.1.2.4. Venture Capital

12.5.4.1.2.5. Liability Management 12.5.4.1.2.6. Second Lien loans

12.5.4.1.2.7. Debt and Equity Recapitalizations 12.5.4.1.2.8. Others

12.5.4.1.3. Others

12.5.4.2.   Germany Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.4.2.1. Small and Medium Organizations 12.5.4.2.2. Large Organizations

12.5.4.3.   Germany Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.4.3.1. Pharmaceuticals

12.5.4.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.4.3.1.2. Biopharma

12.5.4.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.4.3.1.4.                                                                                                 Others

12.5.4.3.2. Healthcare Delivery

12.5.4.3.2.1.    Hospitals

12.5.4.3.2.2.    Managed Care Facilities 12.5.4.3.2.3. Private Practices

12.5.4.3.2.4.    Diagnostics

12.5.4.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.4.3.2.6. Behavioral Health

12.5.4.3.2.7. Pre-Acute and Acute Care 12.5.4.3.2.8. Others

12.5.4.3.3. Medical Technology

12.5.4.3.3.1.    Life Sciences and Diagnostic Tools 12.5.4.3.3.2. Medical Devices and Equipment 12.5.4.3.3.3. Biotechnology

12.5.4.3.3.4. Medical Supplies and Consumables 12.5.4.3.3.5. Others

12.5.4.3.4. Healthcare Information Technology (HCIT) 12.5.4.3.5. Others

12.5.5.   Italy

12.5.5.1.   Italy Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.5.1.1. Advisory Services

12.5.5.1.1.1.    Mergers and Acquisition Advisory Services 12.5.5.1.1.2. Capital Raising

12.5.5.1.1.3.    Strategic Restructurings

12.5.5.1.1.4.    Others

12.5.5.1.2. Capital Markets

12.5.5.1.2.1.    Acquisition Financing

12.5.5.1.2.2.    Project Financing 12.5.5.1.2.3. Equity Private Placement 12.5.5.1.2.4. Venture Capital

12.5.5.1.2.5. Liability Management 12.5.5.1.2.6. Second Lien loans

12.5.5.1.2.7. Debt and Equity Recapitalizations 12.5.5.1.2.8. Others

12.5.5.1.3. Others

12.5.5.2.   Italy Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.5.2.1. Small and Medium Organizations 12.5.5.2.2. Large Organizations

12.5.5.3.   Italy Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.5.3.1. Pharmaceuticals

12.5.5.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.5.3.1.2. Biopharma

12.5.5.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.5.3.1.4.                                                                                                 Others

12.5.5.3.2. Healthcare Delivery

12.5.5.3.2.1.    Hospitals

12.5.5.3.2.2.    Managed Care Facilities 12.5.5.3.2.3. Private Practices

12.5.5.3.2.4.    Diagnostics

12.5.5.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.5.3.2.6. Behavioral Health

12.5.5.3.2.7. Pre-Acute and Acute Care 12.5.5.3.2.8. Others

12.5.5.3.3. Medical Technology

12.5.5.3.3.1.    Life Sciences and Diagnostic Tools 12.5.5.3.3.2. Medical Devices and Equipment 12.5.5.3.3.3. Biotechnology

12.5.5.3.3.4. Medical Supplies and Consumables 12.5.5.3.3.5. Others

12.5.5.3.4. Healthcare Information Technology (HCIT) 12.5.5.3.5. Others

12.5.6.   Nordic Countries

12.5.6.1.   Nordic Countries Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.6.1.1. Advisory Services

12.5.6.1.1.1.    Mergers and Acquisition Advisory Services 12.5.6.1.1.2. Capital Raising

12.5.6.1.1.3.    Strategic Restructurings

12.5.6.1.1.4.    Others

12.5.6.1.2. Capital Markets

12.5.6.1.2.1.    Acquisition Financing

12.5.6.1.2.2.    Project Financing 12.5.6.1.2.3. Equity Private Placement 12.5.6.1.2.4. Venture Capital

12.5.6.1.2.5. Liability Management 12.5.6.1.2.6. Second Lien loans

12.5.6.1.2.7. Debt and Equity Recapitalizations 12.5.6.1.2.8. Others

12.5.6.1.3. Others

12.5.6.2.   Nordic Countries Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.6.2.1. Small and Medium Organizations 12.5.6.2.2. Large Organizations

12.5.6.3.   Nordic Countries Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.6.3.1. Pharmaceuticals

12.5.6.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.6.3.1.2. Biopharma

12.5.6.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.6.3.1.4.                                                                                                 Others

12.5.6.3.2. Healthcare Delivery

12.5.6.3.2.1.    Hospitals

12.5.6.3.2.2.    Managed Care Facilities 12.5.6.3.2.3. Private Practices

12.5.6.3.2.4.    Diagnostics

12.5.6.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.6.3.2.6. Behavioral Health

12.5.6.3.2.7. Pre-Acute and Acute Care 12.5.6.3.2.8. Others

12.5.6.3.3. Medical Technology

12.5.6.3.3.1.    Life Sciences and Diagnostic Tools 12.5.6.3.3.2. Medical Devices and Equipment 12.5.6.3.3.3. Biotechnology

12.5.6.3.3.4. Medical Supplies and Consumables 12.5.6.3.3.5. Others

12.5.6.3.4. Healthcare Information Technology (HCIT) 12.5.6.3.5. Others

12.5.6.4.   Nordic Countries Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

12.5.6.4.1. Denmark

12.5.6.4.2. Finland

12.5.6.4.3. Iceland

12.5.6.4.4. Sweden

12.5.6.4.5. Norway

12.5.7.   Benelux Union

12.5.7.1.   Benelux Union Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.7.1.1. Advisory Services

12.5.7.1.1.1.    Mergers and Acquisition Advisory Services 12.5.7.1.1.2. Capital Raising

12.5.7.1.1.3.    Strategic Restructurings

12.5.7.1.1.4.    Others

12.5.7.1.2. Capital Markets

12.5.7.1.2.1.    Acquisition Financing

12.5.7.1.2.2.    Project Financing 12.5.7.1.2.3. Equity Private Placement 12.5.7.1.2.4. Venture Capital

12.5.7.1.2.5. Liability Management 12.5.7.1.2.6. Second Lien loans

12.5.7.1.2.7. Debt and Equity Recapitalizations 12.5.7.1.2.8. Others

12.5.7.1.3. Others

12.5.7.2.   Benelux Union Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.7.2.1. Small and Medium Organizations 12.5.7.2.2. Large Organizations

12.5.7.3.   Benelux Union Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.7.3.1. Pharmaceuticals

12.5.7.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.7.3.1.2. Biopharma

12.5.7.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.7.3.1.4.                                                                                                 Others

12.5.7.3.2. Healthcare Delivery

12.5.7.3.2.1.    Hospitals

12.5.7.3.2.2.    Managed Care Facilities 12.5.7.3.2.3. Private Practices

12.5.7.3.2.4.    Diagnostics

12.5.7.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.7.3.2.6. Behavioral Health

12.5.7.3.2.7. Pre-Acute and Acute Care 12.5.7.3.2.8. Others

12.5.7.3.3. Medical Technology

12.5.7.3.3.1.    Life Sciences and Diagnostic Tools 12.5.7.3.3.2. Medical Devices and Equipment 12.5.7.3.3.3. Biotechnology

12.5.7.3.3.4. Medical Supplies and Consumables 12.5.7.3.3.5. Others

12.5.7.3.4. Healthcare Information Technology (HCIT) 12.5.7.3.5. Others

12.5.7.4.   Benelux Union Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

12.5.7.4.1. Belgium

12.5.7.4.2. The Netherlands

12.5.7.4.3. Luxembourg

12.5.8.   Rest of Europe

12.5.8.1.   Rest of Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

12.5.8.1.1. Advisory Services

12.5.8.1.1.1.    Mergers and Acquisition Advisory Services 12.5.8.1.1.2. Capital Raising

12.5.8.1.1.3.    Strategic Restructurings

12.5.8.1.1.4.    Others

12.5.8.1.2. Capital Markets

12.5.8.1.2.1.    Acquisition Financing

12.5.8.1.2.2.    Project Financing 12.5.8.1.2.3. Equity Private Placement 12.5.8.1.2.4. Venture Capital

12.5.8.1.2.5. Liability Management 12.5.8.1.2.6. Second Lien loans

12.5.8.1.2.7. Debt and Equity Recapitalizations 12.5.8.1.2.8. Others

12.5.8.1.3. Others

12.5.8.2.   Rest of Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

12.5.8.2.1. Small and Medium Organizations 12.5.8.2.2. Large Organizations

12.5.8.3.   Rest of Europe Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

12.5.8.3.1. Pharmaceuticals

12.5.8.3.1.1.    Generics and Specialty Pharmaceuticals 12.5.8.3.1.2. Biopharma

12.5.8.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

12.5.8.3.1.4.                                                                                                 Others

12.5.8.3.2. Healthcare Delivery

12.5.8.3.2.1.    Hospitals

12.5.8.3.2.2.    Managed Care Facilities 12.5.8.3.2.3. Private Practices

12.5.8.3.2.4.    Diagnostics

12.5.8.3.2.5.    Home Health, Hospice and Other Post-Acute 12.5.8.3.2.6. Behavioral Health

12.5.8.3.2.7. Pre-Acute and Acute Care 12.5.8.3.2.8. Others

12.5.8.3.3. Medical Technology

12.5.8.3.3.1.    Life Sciences and Diagnostic Tools 12.5.8.3.3.2. Medical Devices and Equipment 12.5.8.3.3.3. Biotechnology

12.5.8.3.3.4. Medical Supplies and Consumables 12.5.8.3.3.5. Others

12.5.8.3.4. Healthcare Information Technology (HCIT) 12.5.8.3.5. Others

12.6.   Key Segment for Channeling Investments

12.6.1.   By Country

12.6.2.   By Services

12.6.3.   By Organization Size

12.6.4.   By Sector

13.   Asia Pacific Healthcare Investment Banking Market Analysis and Forecasts, 2022 - 2030

13.1.   Overview

13.1.1.   Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn)

13.2.  Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.2.1.   Advisory Services

13.2.1.1.   Mergers and Acquisition Advisory Services

13.2.1.2.   Capital Raising

13.2.1.3.   Strategic Restructurings

13.2.1.4.   Others

13.2.2.   Capital Markets

13.2.2.1.   Acquisition Financing

13.2.2.2.   Project Financing

13.2.2.3.   Equity Private Placement

13.2.2.4.   Venture Capital

13.2.2.5.   Liability Management

13.2.2.6.   Second Lien loans

13.2.2.7.   Debt and Equity Recapitalizations

13.2.2.8.   Others

13.2.3.   Others

13.3.  Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.3.1.   Small and Medium Organizations

13.3.2.   Large Organizations

13.4.  Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.4.1.   Pharmaceuticals

13.4.1.1.   Generics and Specialty Pharmaceuticals

13.4.1.2.   Biopharma

13.4.1.3.   Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.4.1.4.   Others

13.4.2.   Healthcare Delivery

13.4.2.1.   Hospitals

13.4.2.2.   Managed Care Facilities

13.4.2.3.   Private Practices

13.4.2.4.   Diagnostics

13.4.2.5.   Home Health, Hospice and Other Post-Acute

13.4.2.6.   Behavioral Health

13.4.2.7.   Pre-Acute and Acute Care

13.4.2.8.   Others

13.4.3.   Medical Technology

13.4.3.1.   Life Sciences and Diagnostic Tools

13.4.3.2.   Medical Devices and Equipment

13.4.3.3.   Biotechnology

13.4.3.4.   Medical Supplies and Consumables

13.4.3.5.   Others

13.4.4.   Healthcare Information Technology (HCIT)

13.4.5.   Others

13.5.  Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

13.5.1.   China

13.5.1.1.   China Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.1.1.1. Advisory Services

13.5.1.1.1.1.    Mergers and Acquisition Advisory Services 13.5.1.1.1.2. Capital Raising

13.5.1.1.1.3.    Strategic Restructurings

13.5.1.1.1.4.    Others

13.5.1.1.2. Capital Markets

13.5.1.1.2.1.    Acquisition Financing

13.5.1.1.2.2.    Project Financing 13.5.1.1.2.3. Equity Private Placement 13.5.1.1.2.4. Venture Capital

13.5.1.1.2.5. Liability Management 13.5.1.1.2.6. Second Lien loans

13.5.1.1.2.7. Debt and Equity Recapitalizations 13.5.1.1.2.8. Others

13.5.1.1.3. Others

13.5.1.2.   China Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.1.2.1. Small and Medium Organizations 13.5.1.2.2. Large Organizations

13.5.1.3.   China Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.1.3.1. Pharmaceuticals

13.5.1.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.1.3.1.2. Biopharma

13.5.1.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.1.3.1.4.                                                                                                 Others

13.5.1.3.2. Healthcare Delivery

13.5.1.3.2.1.    Hospitals

13.5.1.3.2.2.    Managed Care Facilities 13.5.1.3.2.3. Private Practices

13.5.1.3.2.4.    Diagnostics

13.5.1.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.1.3.2.6. Behavioral Health

13.5.1.3.2.7. Pre-Acute and Acute Care 13.5.1.3.2.8. Others

13.5.1.3.3. Medical Technology

13.5.1.3.3.1.    Life Sciences and Diagnostic Tools 13.5.1.3.3.2. Medical Devices and Equipment 13.5.1.3.3.3. Biotechnology

13.5.1.3.3.4. Medical Supplies and Consumables 13.5.1.3.3.5. Others

13.5.1.3.4. Healthcare Information Technology (HCIT) 13.5.1.3.5. Others

13.5.2.   Japan

13.5.2.1.   Japan Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.2.1.1. Advisory Services

13.5.2.1.1.1.    Mergers and Acquisition Advisory Services 13.5.2.1.1.2. Capital Raising

13.5.2.1.1.3.    Strategic Restructurings

13.5.2.1.1.4.    Others

13.5.2.1.2. Capital Markets

13.5.2.1.2.1.    Acquisition Financing

13.5.2.1.2.2.    Project Financing 13.5.2.1.2.3. Equity Private Placement 13.5.2.1.2.4. Venture Capital

13.5.2.1.2.5. Liability Management 13.5.2.1.2.6. Second Lien loans

13.5.2.1.2.7. Debt and Equity Recapitalizations 13.5.2.1.2.8. Others

13.5.2.1.3. Others

13.5.2.2.   Japan Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.2.2.1. Small and Medium Organizations 13.5.2.2.2. Large Organizations

13.5.2.3.   Japan Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.2.3.1. Pharmaceuticals

13.5.2.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.2.3.1.2. Biopharma

13.5.2.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.2.3.1.4.                                                                                                 Others

13.5.2.3.2. Healthcare Delivery

13.5.2.3.2.1.    Hospitals

13.5.2.3.2.2.    Managed Care Facilities 13.5.2.3.2.3. Private Practices

13.5.2.3.2.4.    Diagnostics

13.5.2.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.2.3.2.6. Behavioral Health

13.5.2.3.2.7. Pre-Acute and Acute Care 13.5.2.3.2.8. Others

13.5.2.3.3. Medical Technology

13.5.2.3.3.1.    Life Sciences and Diagnostic Tools 13.5.2.3.3.2. Medical Devices and Equipment 13.5.2.3.3.3. Biotechnology

13.5.2.3.3.4. Medical Supplies and Consumables 13.5.2.3.3.5. Others

13.5.2.3.4. Healthcare Information Technology (HCIT) 13.5.2.3.5. Others

13.5.3.   India

13.5.3.1.   India Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.3.1.1. Advisory Services

13.5.3.1.1.1.    Mergers and Acquisition Advisory Services 13.5.3.1.1.2. Capital Raising

13.5.3.1.1.3.    Strategic Restructurings

13.5.3.1.1.4.    Others

13.5.3.1.2. Capital Markets

13.5.3.1.2.1.    Acquisition Financing

13.5.3.1.2.2.    Project Financing 13.5.3.1.2.3. Equity Private Placement 13.5.3.1.2.4. Venture Capital

13.5.3.1.2.5. Liability Management 13.5.3.1.2.6. Second Lien loans

13.5.3.1.2.7. Debt and Equity Recapitalizations 13.5.3.1.2.8. Others

13.5.3.1.3. Others

13.5.3.2.   India Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.3.2.1. Small and Medium Organizations 13.5.3.2.2. Large Organizations

13.5.3.3.   India Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.3.3.1. Pharmaceuticals

13.5.3.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.3.3.1.2. Biopharma

13.5.3.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.3.3.1.4.                                                                                                 Others

13.5.3.3.2. Healthcare Delivery

13.5.3.3.2.1.    Hospitals

13.5.3.3.2.2.    Managed Care Facilities 13.5.3.3.2.3. Private Practices

13.5.3.3.2.4.    Diagnostics

13.5.3.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.3.3.2.6. Behavioral Health

13.5.3.3.2.7. Pre-Acute and Acute Care 13.5.3.3.2.8. Others

13.5.3.3.3. Medical Technology

13.5.3.3.3.1.    Life Sciences and Diagnostic Tools 13.5.3.3.3.2. Medical Devices and Equipment 13.5.3.3.3.3. Biotechnology

13.5.3.3.3.4. Medical Supplies and Consumables 13.5.3.3.3.5. Others

13.5.3.3.4. Healthcare Information Technology (HCIT) 13.5.3.3.5. Others

13.5.4.   New Zealand

13.5.4.1.   New Zealand Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.4.1.1. Advisory Services

13.5.4.1.1.1.    Mergers and Acquisition Advisory Services 13.5.4.1.1.2. Capital Raising

13.5.4.1.1.3.    Strategic Restructurings

13.5.4.1.1.4.    Others

13.5.4.1.2. Capital Markets

13.5.4.1.2.1.    Acquisition Financing

13.5.4.1.2.2.    Project Financing 13.5.4.1.2.3. Equity Private Placement 13.5.4.1.2.4. Venture Capital

13.5.4.1.2.5. Liability Management 13.5.4.1.2.6. Second Lien loans

13.5.4.1.2.7. Debt and Equity Recapitalizations 13.5.4.1.2.8. Others

13.5.4.1.3. Others

13.5.4.2.   New Zealand Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.4.2.1. Small and Medium Organizations 13.5.4.2.2. Large Organizations

13.5.4.3.   New Zealand Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.4.3.1. Pharmaceuticals

13.5.4.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.4.3.1.2. Biopharma

13.5.4.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.4.3.1.4.                                                                                                 Others

13.5.4.3.2. Healthcare Delivery

13.5.4.3.2.1.    Hospitals

13.5.4.3.2.2.    Managed Care Facilities 13.5.4.3.2.3. Private Practices

13.5.4.3.2.4.    Diagnostics

13.5.4.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.4.3.2.6. Behavioral Health

13.5.4.3.2.7. Pre-Acute and Acute Care 13.5.4.3.2.8. Others

13.5.4.3.3. Medical Technology

13.5.4.3.3.1.    Life Sciences and Diagnostic Tools 13.5.4.3.3.2. Medical Devices and Equipment 13.5.4.3.3.3. Biotechnology

13.5.4.3.3.4. Medical Supplies and Consumables 13.5.4.3.3.5. Others

13.5.4.3.4. Healthcare Information Technology (HCIT) 13.5.4.3.5. Others

13.5.5.   Australia

13.5.5.1.   Australia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.5.1.1. Advisory Services

13.5.5.1.1.1.    Mergers and Acquisition Advisory Services 13.5.5.1.1.2. Capital Raising

13.5.5.1.1.3.    Strategic Restructurings

13.5.5.1.1.4.    Others

13.5.5.1.2. Capital Markets

13.5.5.1.2.1.    Acquisition Financing

13.5.5.1.2.2.    Project Financing 13.5.5.1.2.3. Equity Private Placement 13.5.5.1.2.4. Venture Capital

13.5.5.1.2.5. Liability Management 13.5.5.1.2.6. Second Lien loans

13.5.5.1.2.7. Debt and Equity Recapitalizations 13.5.5.1.2.8. Others

13.5.5.1.3. Others

13.5.5.2.   Australia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.5.2.1. Small and Medium Organizations 13.5.5.2.2. Large Organizations

13.5.5.3.   Australia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.5.3.1. Pharmaceuticals

13.5.5.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.5.3.1.2. Biopharma

13.5.5.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.5.3.1.4.                                                                                                 Others

13.5.5.3.2. Healthcare Delivery

13.5.5.3.2.1.    Hospitals

13.5.5.3.2.2.    Managed Care Facilities 13.5.5.3.2.3. Private Practices

13.5.5.3.2.4.    Diagnostics

13.5.5.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.5.3.2.6. Behavioral Health

13.5.5.3.2.7. Pre-Acute and Acute Care 13.5.5.3.2.8. Others

13.5.5.3.3. Medical Technology

13.5.5.3.3.1.    Life Sciences and Diagnostic Tools 13.5.5.3.3.2. Medical Devices and Equipment 13.5.5.3.3.3. Biotechnology

13.5.5.3.3.4. Medical Supplies and Consumables 13.5.5.3.3.5. Others

13.5.5.3.4. Healthcare Information Technology (HCIT) 13.5.5.3.5. Others

13.5.6.   South Korea

13.5.6.1.   South Korea Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.6.1.1. Advisory Services

13.5.6.1.1.1.    Mergers and Acquisition Advisory Services 13.5.6.1.1.2. Capital Raising

13.5.6.1.1.3.    Strategic Restructurings

13.5.6.1.1.4.    Others

13.5.6.1.2. Capital Markets

13.5.6.1.2.1.    Acquisition Financing

13.5.6.1.2.2.    Project Financing 13.5.6.1.2.3. Equity Private Placement 13.5.6.1.2.4. Venture Capital

13.5.6.1.2.5. Liability Management 13.5.6.1.2.6. Second Lien loans

13.5.6.1.2.7. Debt and Equity Recapitalizations 13.5.6.1.2.8. Others

13.5.6.1.3. Others

13.5.6.2.   South Korea Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.6.2.1. Small and Medium Organizations 13.5.6.2.2. Large Organizations

13.5.6.3.   South Korea Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.6.3.1. Pharmaceuticals

13.5.6.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.6.3.1.2. Biopharma

13.5.6.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.6.3.1.4.                                                                                                 Others

13.5.6.3.2. Healthcare Delivery

13.5.6.3.2.1.    Hospitals

13.5.6.3.2.2.    Managed Care Facilities 13.5.6.3.2.3. Private Practices

13.5.6.3.2.4.    Diagnostics

13.5.6.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.6.3.2.6. Behavioral Health

13.5.6.3.2.7. Pre-Acute and Acute Care 13.5.6.3.2.8. Others

13.5.6.3.3. Medical Technology

13.5.6.3.3.1.    Life Sciences and Diagnostic Tools 13.5.6.3.3.2. Medical Devices and Equipment 13.5.6.3.3.3. Biotechnology

13.5.6.3.3.4. Medical Supplies and Consumables 13.5.6.3.3.5. Others

13.5.6.3.4. Healthcare Information Technology (HCIT) 13.5.6.3.5. Others

13.5.7.   Southeast Asia

13.5.7.1.   Southeast Asia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.7.1.1. Advisory Services

13.5.7.1.1.1.    Mergers and Acquisition Advisory Services 13.5.7.1.1.2. Capital Raising

13.5.7.1.1.3.    Strategic Restructurings

13.5.7.1.1.4.    Others

13.5.7.1.2. Capital Markets

13.5.7.1.2.1.    Acquisition Financing

13.5.7.1.2.2.    Project Financing 13.5.7.1.2.3. Equity Private Placement 13.5.7.1.2.4. Venture Capital

13.5.7.1.2.5. Liability Management 13.5.7.1.2.6. Second Lien loans

13.5.7.1.2.7. Debt and Equity Recapitalizations 13.5.7.1.2.8. Others

13.5.7.1.3. Others

13.5.7.2.   Southeast Asia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.7.2.1. Small and Medium Organizations 13.5.7.2.2. Large Organizations

13.5.7.3.   Southeast Asia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.7.3.1. Pharmaceuticals

13.5.7.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.7.3.1.2. Biopharma

13.5.7.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.7.3.1.4.                                                                                                 Others

13.5.7.3.2. Healthcare Delivery

13.5.7.3.2.1.    Hospitals

13.5.7.3.2.2.    Managed Care Facilities 13.5.7.3.2.3. Private Practices

13.5.7.3.2.4.    Diagnostics

13.5.7.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.7.3.2.6. Behavioral Health

13.5.7.3.2.7. Pre-Acute and Acute Care 13.5.7.3.2.8. Others

13.5.7.3.3. Medical Technology

13.5.7.3.3.1.    Life Sciences and Diagnostic Tools 13.5.7.3.3.2. Medical Devices and Equipment 13.5.7.3.3.3. Biotechnology

13.5.7.3.3.4. Medical Supplies and Consumables 13.5.7.3.3.5. Others

13.5.7.3.4. Healthcare Information Technology (HCIT)

13.5.7.3.5. Others

13.5.7.4.   Southeast Asia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

13.5.7.4.1. Indonesia

13.5.7.4.2. Thailand

13.5.7.4.3. Malaysia

13.5.7.4.4. Singapore

13.5.7.4.5. Rest of Southeast Asia

13.5.8.   Rest of Asia Pacific

13.5.8.1.   Rest of Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

13.5.8.1.1. Advisory Services

13.5.8.1.1.1.    Mergers and Acquisition Advisory Services 13.5.8.1.1.2. Capital Raising

13.5.8.1.1.3.    Strategic Restructurings

13.5.8.1.1.4.    Others

13.5.8.1.2. Capital Markets

13.5.8.1.2.1.    Acquisition Financing

13.5.8.1.2.2.    Project Financing 13.5.8.1.2.3. Equity Private Placement 13.5.8.1.2.4. Venture Capital

13.5.8.1.2.5. Liability Management 13.5.8.1.2.6. Second Lien loans

13.5.8.1.2.7. Debt and Equity Recapitalizations 13.5.8.1.2.8. Others

13.5.8.1.3. Others

13.5.8.2.   Rest of Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.5.8.2.1. Small and Medium Organizations 13.5.8.2.2. Large Organizations

13.5.8.3.   Rest of Asia Pacific Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

13.5.8.3.1. Pharmaceuticals

13.5.8.3.1.1.    Generics and Specialty Pharmaceuticals 13.5.8.3.1.2. Biopharma

13.5.8.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

13.5.8.3.1.4.                                                                                                 Others

13.5.8.3.2. Healthcare Delivery

13.5.8.3.2.1.    Hospitals

13.5.8.3.2.2.    Managed Care Facilities 13.5.8.3.2.3. Private Practices

13.5.8.3.2.4.    Diagnostics

13.5.8.3.2.5.    Home Health, Hospice and Other Post-Acute 13.5.8.3.2.6. Behavioral Health

13.5.8.3.2.7. Pre-Acute and Acute Care 13.5.8.3.2.8. Others

13.5.8.3.3. Medical Technology

13.5.8.3.3.1.    Life Sciences and Diagnostic Tools 13.5.8.3.3.2. Medical Devices and Equipment 13.5.8.3.3.3. Biotechnology

13.5.8.3.3.4. Medical Supplies and Consumables 13.5.8.3.3.5. Others

13.5.8.3.4. Healthcare Information Technology (HCIT) 13.5.8.3.5. Others

13.6.   Key Segment for Channeling Investments

13.6.1.   By Country

13.6.2.   By Services

13.6.3.   By Organization Size

13.6.4.   By Sector

14.   Middle East and Africa Healthcare Investment Banking Market Analysis and Forecasts, 2022 - 2030

14.1.   Overview

14.1.1.   Middle East and Africa Healthcare Investment Banking Market Revenue (US$ Mn)

14.2.  Middle East and Africa Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

14.2.1.   Advisory Services

14.2.1.1.   Mergers and Acquisition Advisory Services

14.2.1.2.   Capital Raising

14.2.1.3.   Strategic Restructurings

14.2.1.4.   Others

14.2.2.   Capital Markets

14.2.2.1.   Acquisition Financing

14.2.2.2.   Project Financing

14.2.2.3.   Equity Private Placement

14.2.2.4.   Venture Capital

14.2.2.5.   Liability Management

14.2.2.6.   Second Lien loans

14.2.2.7.   Debt and Equity Recapitalizations

14.2.2.8.   Others

14.2.3.   Others

14.3.  Middle East and Africa Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.3.1.   Small and Medium Organizations

14.3.2.   Large Organizations

14.4.  Middle East and Africa Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

14.4.1.   Pharmaceuticals

14.4.1.1.   Generics and Specialty Pharmaceuticals

14.4.1.2.   Biopharma

14.4.1.3.   Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

14.4.1.4.   Others

14.4.2.   Healthcare Delivery

14.4.2.1.   Hospitals

14.4.2.2.   Managed Care Facilities

14.4.2.3.   Private Practices

14.4.2.4.   Diagnostics

14.4.2.5.   Home Health, Hospice and Other Post-Acute

14.4.2.6.   Behavioral Health

14.4.2.7.   Pre-Acute and Acute Care

14.4.2.8.   Others

14.4.3.   Medical Technology

14.4.3.1.   Life Sciences and Diagnostic Tools

14.4.3.2.   Medical Devices and Equipment

14.4.3.3.   Biotechnology

14.4.3.4.   Medical Supplies and Consumables

14.4.3.5.   Others

14.4.4.   Healthcare Information Technology (HCIT)

14.4.5.   Others

14.5.  Middle East and Africa Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Country

14.5.1.   Saudi Arabia

14.5.1.1.   Saudi Arabia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

14.5.1.1.1. Advisory Services

14.5.1.1.1.1.    Mergers and Acquisition Advisory Services 14.5.1.1.1.2. Capital Raising

14.5.1.1.1.3.    Strategic Restructurings

14.5.1.1.1.4.    Others

14.5.1.1.2. Capital Markets

14.5.1.1.2.1.    Acquisition Financing

14.5.1.1.2.2.    Project Financing 14.5.1.1.2.3. Equity Private Placement 14.5.1.1.2.4. Venture Capital

14.5.1.1.2.5. Liability Management 14.5.1.1.2.6. Second Lien loans

14.5.1.1.2.7. Debt and Equity Recapitalizations 14.5.1.1.2.8. Others

14.5.1.1.3. Others

14.5.1.2.   Saudi Arabia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.5.1.2.1. Small and Medium Organizations 14.5.1.2.2. Large Organizations

14.5.1.3.   Saudi Arabia Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Sector

14.5.1.3.1. Pharmaceuticals

14.5.1.3.1.1.    Generics and Specialty Pharmaceuticals 14.5.1.3.1.2. Biopharma

14.5.1.3.1.3. Pharmaceutical Services (Contract Development and Manufacturing Organizations (CDMO), Contract Research Organizations (CRO), Etc.)

14.5.1.3.1.4.                                                                                                 Others

14.5.1.3.2. Healthcare Delivery

14.5.1.3.2.1.    Hospitals

14.5.1.3.2.2.    Managed Care Facilities 14.5.1.3.2.3. Private Practices

14.5.1.3.2.4.    Diagnostics

14.5.1.3.2.5.    Home Health, Hospice and Other Post-Acute 14.5.1.3.2.6. Behavioral Health

14.5.1.3.2.7. Pre-Acute and Acute Care 14.5.1.3.2.8. Others

14.5.1.3.3. Medical Technology

14.5.1.3.3.1.    Life Sciences and Diagnostic Tools 14.5.1.3.3.2. Medical Devices and Equipment 14.5.1.3.3.3. Biotechnology

14.5.1.3.3.4. Medical Supplies and Consumables 14.5.1.3.3.5. Others

14.5.2.   UAE

14.5.2.1.1. Healthcare Information Technology (HCIT) 14.5.1.3.5. Others

14.5.2.2.   UAE Healthcare Investment Banking Market Revenue (US$ Mn) and Forecasts, By Services

14.5.2.2.1. Advisory Services

14.5.2.2.1.1.    Mergers and Acquisition Advisory Services 14.5.2.1.1.2. Capital Raising

14.5.2.1.1.3.    Strategic Restructurings

14.5.2.1.1.4.    Others

14.5.2.2.2. Capital Markets

14.5.2.2.2.1.    Acquisition Financing

14.5.2.2.2.2.    Project Financing 14.5.2.1.2.3. Equity Private Placement 14.5.2.1.2.4. Venture Capital

14.5.2.1.2.5. Liability Management 14.5.2.1.2.6. Second Lien loans